Business Description
ImmunityBio Inc
NAICS : 541714
SIC : 8731
ISIN : US45256X1037
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.3 | |||||
Equity-to-Asset | -1.57 | |||||
Debt-to-Equity | -1.05 | |||||
Debt-to-EBITDA | -1.69 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -11.76 | |||||
Beneish M-Score | -3.01 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.6 | |||||
3-Year EBITDA Growth Rate | -17.2 | |||||
3-Year EPS without NRI Growth Rate | -24 | |||||
3-Year FCF Growth Rate | -19.9 | |||||
3-Year Book Growth Rate | -40.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 23.46 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 681.15 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.29 | |||||
9-Day RSI | 48.14 | |||||
14-Day RSI | 47.3 | |||||
6-1 Month Momentum % | -32.23 | |||||
12-1 Month Momentum % | 158.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.91 | |||||
Quick Ratio | 3.88 | |||||
Cash Ratio | 3.51 | |||||
Days Sales Outstanding | 288.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20.5 | |||||
Shareholder Yield % | -1.03 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -27459.33 | |||||
Net Margin % | -45691.67 | |||||
FCF Margin % | -32429.24 | |||||
ROA % | -144.14 | |||||
ROIC % | -106.43 | |||||
3-Year ROIIC % | -150.96 | |||||
ROC (Joel Greenblatt) % | -247.1 | |||||
ROCE % | -190 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1775 | |||||
EV-to-EBIT | -6.52 | |||||
EV-to-EBITDA | -6.8 | |||||
EV-to-Revenue | 2265.2 | |||||
EV-to-FCF | -7.03 | |||||
Earnings Yield (Greenblatt) % | -15.34 | |||||
FCF Yield % | -17.42 |